Find comprehensive information on lung tumor diagnosis, including clinical documentation, medical coding (ICD-10, SNOMED CT), and healthcare resources. Learn about lung cancer types, staging, symptoms, and treatment options. Explore resources for patients, physicians, and coding professionals related to lung neoplasm, pulmonary nodule, and thoracic oncology. This resource provides guidance on proper documentation for lung tumor diagnosis and relevant medical coding terminology for accurate billing and reimbursement.
Also known as
Malignant neoplasm of bronchus/lung
Cancer originating in the bronchi or lungs.
Benign neoplasm of bronchus/lung
Non-cancerous tumor in the bronchi or lungs.
Neoplasm of uncertain behavior of lung
Lung tumor with unknown potential to spread.
Abnormal findings on lung imaging
Unspecified abnormal results from lung scans/x-rays.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the lung tumor malignant?
When to use each related code
| Description |
|---|
| Lung Tumor |
| Lung Cancer |
| Pulmonary Nodule |
Inaccurate coding of tumor histology (e.g., small cell vs. non-small cell) impacting treatment and reimbursement.
Missing or unclear documentation of lung affected (right, left, or bilateral) leading to coding errors and claims denials.
Incomplete staging data (TNM) affecting accurate code assignment and appropriate severity reflection for DRG assignment.
Patient presents with complaints suggestive of a lung tumor, including persistent cough, hemoptysis, dyspnea, chest pain, and unintentional weight loss. On physical examination, findings may include diminished breath sounds, wheezing, or pleural effusion. Imaging studies, such as chest X-ray, CT scan of the chest with contrast, and PET scan, are crucial for lung cancer screening, diagnosis, and staging. Pulmonary nodules, masses, and mediastinal lymphadenopathy may be observed. A biopsy, either via bronchoscopy or percutaneous needle aspiration, is necessary for histopathological confirmation of malignancy, classifying the lung neoplasm as small cell lung cancer, non-small cell lung cancer (including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma), or other lung tumor types. Further diagnostic workup may involve pulmonary function tests, blood tests including a complete blood count and comprehensive metabolic panel, and molecular testing for specific genetic mutations to guide targeted therapy selection. Treatment options for lung tumors include surgery (lobectomy, pneumonectomy), radiation therapy (stereotactic body radiation therapy, external beam radiation therapy), chemotherapy, immunotherapy, targeted therapy, or a combination thereof, depending on the stage and type of lung cancer. Palliative care is also an important consideration for symptom management and improving quality of life. Patient education regarding smoking cessation, radon exposure mitigation, and other lung cancer risk factors is essential. Follow-up care, including regular imaging and clinical evaluations, is crucial for monitoring treatment response, detecting recurrence, and managing potential complications. ICD-10 codes C34.0-C34.9 are used for coding malignant neoplasms of the bronchus and lung.